Stock Events

Stock Events

Aytu BioPharma 

$2.03
72
+$0.02+1% 12:27 Today

Statistics

Day High
2.01
Day Low
2
52W High
3.07
52W Low
1.8
Volume
1,439
Avg. Volume
-
Mkt Cap
21.84M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 16Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-2.93
-1.89
-0.84
0.2
Expected EPS
-0.256667
Actual EPS
N/A

Financials

-24.76%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
57.57MRevenue
-14.25MNet Income

Analyst Ratings

$15.00Average Price Target
The highest estimate is ⁦15.00⁩.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AYTU. It's not an investment recommendation.
Microsoft
17
MSFT
Apple
14
AAPL
Alphabet
14
GOOGL
Amazon
13
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a global pharmaceutical company that competes with Aytu BioPharma in the development and marketing of medications in various therapeutic areas.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson operates in the pharmaceutical sector, offering products that could directly compete with Aytu BioPharma's portfolio, especially in pediatrics and other health areas.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie competes in similar therapeutic areas as Aytu BioPharma, including testosterone replacement therapy and other pharmaceuticals.
Merck
MRK
Mkt Cap356.01B
Merck is a leading pharmaceutical company with a broad product line that can compete with Aytu BioPharma's offerings in various health conditions.
Lilly(Eli) &
LLY
Mkt Cap1.02T
Eli Lilly and Company is involved in the development and marketing of pharmaceutical products that could compete with Aytu BioPharma, especially in the areas of men's health.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap46.1B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing with Aytu BioPharma in various therapeutic areas.
Novartis
NVS
Mkt Cap268B
Novartis is a global healthcare company that offers products which could compete with Aytu BioPharma in several therapeutic areas, including pediatrics.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline is a global healthcare company with a wide range of pharmaceutical products that could compete with Aytu BioPharma, especially in respiratory and pediatric medicines.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol Myers Squibb is a global biopharmaceutical company with a diverse portfolio of products that could compete with Aytu BioPharma in various therapeutic areas.

About

Aytu BioPharma Inc is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. It has single operating segment. Its product portfolio includes EXXUA, ADHD Portfolio, Pediatric Portfolio, and Other. Majority of revenue comes from ADHD Portfolio. It has presence in United States.
Show More
CEO
Joshua R. Disbrow
Employees
76
Country
United States
ISIN
US0547548588
WKN
000A3D38R

Listings

MU
DE
AY21.MU
STU
DE
AY21.STU
MU
DE
AY20.MU
XNAS
US
AYTU

0 Comments

Share your thoughts

FAQs

What is Aytu BioPharma stock price today?▼
The current price of AYTU is $2.03 USD — it has increased by +1% in the past 24 hours. Watch Aytu BioPharma stock price performance more closely on the chart.
What is Aytu BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Aytu BioPharma stocks are traded under the ticker AYTU.
Is Aytu BioPharma stock price growing?▼
AYTU stock has risen by +3.08% compared to the previous week, the month change is a -5.41% fall, over the last year Aytu BioPharma has showed a -14.83% decrease.
What is Aytu BioPharma market cap?▼
Today Aytu BioPharma has the market capitalization of 21.84M
When is the next Aytu BioPharma earnings date?▼
Aytu BioPharma is going to release the next earnings report on November 16, 2026.
What were Aytu BioPharma earnings last quarter?▼
AYTU earnings for the last quarter are -0.53 USD per share, whereas the estimation was -0.44 USD resulting in a -19.55% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Aytu BioPharma revenue for the last year?▼
Aytu BioPharma revenue for the last year amounts to 57.57M USD.
What is Aytu BioPharma net income for the last year?▼
AYTU net income for the last year is -14.25M USD.
How many employees does Aytu BioPharma have?▼
As of October 21, 2026, the company has 76 employees.
In which sector is Aytu BioPharma located?▼
Aytu BioPharma operates in the Health & Wellness sector.
When did Aytu BioPharma complete a stock split?▼
The last stock split for Aytu BioPharma was on January 6, 2023 with a ratio of 1:20.
Where is Aytu BioPharma headquartered?▼
Aytu BioPharma is headquartered in DENVER, United States.